Source:http://linkedlifedata.com/resource/pubmed/id/21351377
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9
|
| pubmed:dateCreated |
2011-2-24
|
| pubmed:commentsCorrections | |
| pubmed:language |
ita
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
1827-6806
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
11
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
708-9
|
| pubmed:meshHeading |
pubmed-meshheading:21351377-Cardiovascular Diseases,
pubmed-meshheading:21351377-Clinical Trials as Topic,
pubmed-meshheading:21351377-Dyslipidemias,
pubmed-meshheading:21351377-Humans,
pubmed-meshheading:21351377-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:21351377-Italy,
pubmed-meshheading:21351377-Risk Assessment,
pubmed-meshheading:21351377-Risk Factors
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
[The JUPITER study: an orbit still very far from the Mediterranean countries].
|
| pubmed:publicationType |
Letter,
Comment
|